Node-based differential network analysis in genomics
暂无分享,去创建一个
[1] Deepa Subramanyam,et al. Notch Signaling Pathway as a Therapeutic Target in Breast Cancer , 2010, Molecular Cancer Therapeutics.
[2] R. Tibshirani,et al. Sparse inverse covariance estimation with the graphical lasso. , 2008, Biostatistics.
[3] D. Srivastava,et al. Mutations in NOTCH1 cause aortic valve disease , 2005, Nature.
[4] Stephen P. Boyd,et al. Distributed Optimization and Statistical Learning via the Alternating Direction Method of Multipliers , 2011, Found. Trends Mach. Learn..
[5] A. Fuente,et al. From ‘differential expression’ to ‘differential networking’ – identification of dysfunctional regulatory networks in diseases , 2010 .
[6] Patrick Danaher,et al. The joint graphical lasso for inverse covariance estimation across multiple classes , 2011, Journal of the Royal Statistical Society. Series B, Statistical methodology.
[7] N. Eckstein,et al. Platinum resistance in breast and ovarian cancer cell lines , 2011, Journal of experimental & clinical cancer research : CR.
[8] Xiaohua Hu,et al. Identifying binary protein-protein interactions from affinity purification mass spectrometry data , 2015, BMC Genomics.
[9] Elisa de Stanchina,et al. Overcoming mTOR Resistance Mutations with a New Generation mTOR Inhibitor , 2016, Nature.
[10] Peng Yang,et al. Detecting temporal protein complexes from dynamic protein-protein interaction networks , 2014, BMC Bioinformatics.
[11] E. Levina,et al. Joint estimation of multiple graphical models. , 2011, Biometrika.
[12] Tzu-Hao Chang,et al. COL11A1 confers chemoresistance on ovarian cancer cells through the activation of Akt/c/EBPβ pathway and PDK1 stabilization , 2015, Oncotarget.
[13] D. Govender,et al. Gene of the month: KIT , 2015, Journal of Clinical Pathology.
[14] Shiying Yu,et al. Notch signaling: an emerging therapeutic target for cancer treatment. , 2015, Cancer letters.
[15] Hong Yan,et al. Comparative analysis of housekeeping and tissue-specific driver nodes in human protein interaction networks , 2016, BMC Bioinformatics.
[16] Stephen P. Boyd,et al. Proximal Algorithms , 2013, Found. Trends Optim..
[17] H. Burris,et al. Overcoming acquired resistance to anticancer therapy: focus on the PI3K/AKT/mTOR pathway , 2013, Cancer Chemotherapy and Pharmacology.
[18] Ruibin Xi,et al. Differential Network Analysis via the Lasso Penalized D-Trace Loss , 2015, 1511.09188.
[19] Nir Friedman,et al. Inferring Cellular Networks Using Probabilistic Graphical Models , 2004, Science.
[20] Hong Yan,et al. Differential network analysis from cross-platform gene expression data , 2016, Scientific Reports.
[21] Su-In Lee,et al. Identifying Network Perturbation in Cancer , 2016, bioRxiv.
[22] Yingying Lu,et al. Inhibition of telomerase activity by HDV ribozyme in cancers , 2011, Journal of experimental & clinical cancer research : CR.
[23] Roland H Wenger,et al. Intermittent hypoxia confers pro-metastatic gene expression selectively through NF-κB in inflammatory breast cancer cells. , 2016, Free radical biology & medicine.
[24] Benjamin J. Raphael,et al. Integrated Genomic Analyses of Ovarian Carcinoma , 2011, Nature.
[25] Feihu Huang,et al. Joint Learning of Multiple Sparse Matrix Gaussian Graphical Models , 2015, IEEE Transactions on Neural Networks and Learning Systems.
[26] T. Ideker,et al. Differential network biology , 2012, Molecular systems biology.
[27] Andrew H. Beck,et al. EMDomics: a robust and powerful method for the identification of genes differentially expressed between heterogeneous classes , 2015, Bioinform..
[28] V. Beral,et al. Rethinking ovarian cancer II: reducing mortality from high-grade serous ovarian cancer , 2015, Nature Reviews Cancer.
[29] Quanquan Gu,et al. Identifying gene regulatory network rewiring using latent differential graphical models , 2016, Nucleic acids research.
[30] Susumu Goto,et al. KEGG for representation and analysis of molecular networks involving diseases and drugs , 2009, Nucleic Acids Res..
[31] Susmita Datta,et al. A statistical framework for differential network analysis from microarray data , 2010, BMC Bioinformatics.
[32] Xiao-Fei Zhang,et al. Determining minimum set of driver nodes in protein-protein interaction networks , 2015, BMC Bioinformatics.
[33] G. Sapiro,et al. A collaborative framework for 3D alignment and classification of heterogeneous subvolumes in cryo-electron tomography. , 2013, Journal of structural biology.
[34] Markku Miettinen,et al. KIT (CD117): A Review on Expression in Normal and Neoplastic Tissues, and Mutations and Their Clinicopathologic Correlation , 2005, Applied immunohistochemistry & molecular morphology : AIMM.
[35] Su-In Lee,et al. Learning graphical models with hubs , 2014, J. Mach. Learn. Res..
[36] Kim-Anh Do,et al. DINGO: differential network analysis in genomics , 2015, Bioinform..
[37] T. Cai,et al. Direct estimation of differential networks. , 2014, Biometrika.
[38] Adrian V. Lee,et al. Oncogenic Transformation by the Signaling Adaptor Proteins Insulin Receptor Substrate (IRS)-1 and IRS-2 , 2007, Cell cycle.
[39] A. Barabasi,et al. Network medicine : a network-based approach to human disease , 2010 .
[40] Su-In Lee,et al. Node-based learning of multiple Gaussian graphical models , 2013, J. Mach. Learn. Res..
[41] Su-In Lee,et al. Pathway Graphical Lasso , 2015, AAAI.
[42] Robert Maurer,et al. KIT (CD117)-Positive Breast Cancers Are Infrequent and Lack KIT Gene Mutations , 2004, Clinical Cancer Research.
[43] H. Zou,et al. Sparse precision matrix estimation via lasso penalized D-trace loss , 2014 .
[44] Rainer Spang,et al. Inferring cellular networks – a review , 2007, BMC Bioinformatics.
[45] Yufeng Liu,et al. Joint estimation of multiple precision matrices with common structures , 2015, J. Mach. Learn. Res..
[46] D. Soprano,et al. Insulin receptor substrate-1 is an important mediator of ovarian cancer cell growth suppression by all-trans retinoic acid. , 2007, Cancer research.
[47] M. Yuan,et al. Model selection and estimation in the Gaussian graphical model , 2007 .
[48] Kodi S Ravichandran,et al. Signaling via Shc family adapter proteins , 2001, Oncogene.
[49] Shiying Yu,et al. Expression of Notch1 Correlates with Breast Cancer Progression and Prognosis , 2015, PloS one.
[50] Nanny Wermuth,et al. Multivariate Dependencies: Models, Analysis and Interpretation , 1996 .
[51] M. Dietel,et al. PDK1 is Expressed in Ovarian Serous Carcinoma and Correlates with Improved Survival in High-grade Tumors. , 2015, Anticancer research.
[52] Pei Wang,et al. Partial Correlation Estimation by Joint Sparse Regression Models , 2008, Journal of the American Statistical Association.
[53] David Holmes,et al. Ovarian cancer: beyond resistance , 2015, Nature.
[54] Adam J. Rothman,et al. Sparse permutation invariant covariance estimation , 2008, 0801.4837.